Trends in the development of antithrombotic agents.
作者信息
Hampton J
出版信息
Am J Cardiol. 1971 Jun;27(6):659-69. doi: 10.1016/0002-9149(71)90232-3.
PMID:4397351
Abstract
摘要
相似文献
1
Trends in the development of antithrombotic agents.抗血栓形成药物的发展趋势。
Am J Cardiol. 1971 Jun;27(6):659-69. doi: 10.1016/0002-9149(71)90232-3.
2
Management of thrombotic diseases.血栓性疾病的管理
Semin Hematol. 1971 Apr;8(2):95-139.
3
Prophylaxis of venous thromboembolism.静脉血栓栓塞的预防
Proc R Soc Med. 1975 Apr;68(4):263-4. doi: 10.1177/003591577506800436.
4
Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
Circulation. 1972 Apr;45(4):911-8. doi: 10.1161/01.cir.45.4.911.
5
Prophylaxis of pulmonary embolism.肺栓塞的预防
Br Med J. 1970 Jun 27;2(5712):780-2. doi: 10.1136/bmj.2.5712.780.
6
Reduction in venous thromboembolism by agents affecting platelet function.
N Engl J Med. 1971 Jun 10;284(23):1287-92. doi: 10.1056/NEJM197106102842303.
7
[Inhibition of platelet aggregation: experimental findings and clinical prospects].
Nouv Rev Fr Hematol. 1971 May-Jun;11(3):339-63.
8
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].[摘要：影响血小板行为的药物；实验与临床数据（作者译）]
Ther Umsch. 1974 Feb;31(2):84-8.
9
[Current status of the prevention of pulmonary embolism].[肺栓塞预防的现状]
Minerva Chir. 1980;35(23-24):1827-34.
10
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
N Engl J Med. 1975 Dec 18;293(25):1296-300. doi: 10.1056/NEJM197512182932506.
Zotero 插件